Riskpilot← Back to searchSign inGet full accessHuman Tech Medica Scandinavia AB
ABActiveOrg 5567940639Kullasandsliden 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20091 employees
Revenue 2024
SEK 4,8M
+40% vs 2023
EBITDA margin
13.6%
-36% vs 2023
Equity ratio
65.2%
Financial strength
Net profit 2024
SEK 551K
-40% vs 2023
| Revenue | SEK 4,8M | +40% |
| EBITDA | SEK 652K | -36% |
| Net profit | SEK 551K | -40% |
| Total assets | SEK 3,7M | +34% |
| Equity | SEK 2,4M | +30% |
| Employees | 1 | — |
Legal name
Human Tech Medica Scandinavia AB
Org number
5567940639
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 november 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva inköp och försäljning av medicinsk utrustning till offentlig och privat sjukvård samt handel och förvaltning av värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Kullasandsliden 2
Email
peter.olander@humantechmedica.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 121 | 2 729 | 3 173 | 3 427 | 4 802 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 572 | −3 | 404 | 1 014 | 652 |
| Depreciation & amort. | −8 | −2 | −2 | −2 | −2 |
| EBIT | 564 | −5 | 402 | 1 012 | 650 |
| Net financials | −1 | −1 | −1 | — | — |
| Profit before tax | 563 | −6 | 401 | 1 012 | 650 |
| Tax | −111 | −3 | −86 | −96 | −99 |
| Net profit | 452 | −9 | 315 | 916 | 551 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 867 | 1 718 | 1 830 | 2 725 | 3 650 |
| Equity | 608 | 599 | 914 | 1 829 | 2 380 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 259 | 1 119 | 917 | 896 | 1 270 |
| Total debt | 1 259 | 1 119 | 917 | 896 | 1 270 |
EBITDA margin
13.6%
This company
15.8%
Market median
-14% vs market
20202024
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20202024
Return on equity
23.2%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
11.5%
This company
8.1%
Market median
+42% vs market
20202024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JH Audit | Audit | 2022 |
MP Chief Executive Officer | Chief Executive Officer | 2024 |
LP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Human Tech Medica Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Henrik Johansson | Audit | 0 companies |
| Marcus Peter Mörk | Chief Executive Officer | 0 companies |
| Lars Peter Olander | Deputy Chief Executive Officer | 0 companies |
| Ingrid Lena Margareta Olander | Deputy Board Member | 0 companies |